Saturn V Capital Management LP
Q1 2026 13F Holdings
- Locationaustin, TX
- Num holdings
21
- Value ($000)
$552,218
- Date Filed 05/15/2026
- Form type13F-HR
- CIK 0001964437
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ALUMIS INC | COM | 022307102 | $70.54M | 13 % | 3,202,075 | ||
AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | $60.46M | 11 % | 4,349,885 | ||
ABIVAX SA | SPONSORED ADS | 00370M103 | $60.43M | 11 % | 542,696 | ||
VAXCYTE INC | COM | 92243G108 | $47.91M | 9 % | 824,532 | ||
PHARVARIS N V | COM | N69605108 | $33.94M | 6 % | 1,201,402 | ||
IMMIX BIOPHARMA INC | COM | 45258H106 | $33.65M | 6 % | 3,693,585 | ||
CELCUITY INC | COM | 15102K100 | $32.18M | 6 % | 281,904 | ||
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | $30.81M | 6 % | 162,961 | ||
DISC MEDICINE INC | COM | 254604101 | $28.77M | 5 % | 449,926 | ||
X4 PHARMACEUTICALS INC | COM NEW | 98420X202 | $26.67M | 5 % | 6,456,646 |
Rows Per Page
10
- 10
- 50
- 100